JPS57112344A - Pharmacological 4-(2-hydroxy-4-(substituted)phenyl)- naphthalene-2(1h)-one and 2-ol, their derivatives and their intermediates - Google Patents

Pharmacological 4-(2-hydroxy-4-(substituted)phenyl)- naphthalene-2(1h)-one and 2-ol, their derivatives and their intermediates

Info

Publication number
JPS57112344A
JPS57112344A JP56147723A JP14772381A JPS57112344A JP S57112344 A JPS57112344 A JP S57112344A JP 56147723 A JP56147723 A JP 56147723A JP 14772381 A JP14772381 A JP 14772381A JP S57112344 A JPS57112344 A JP S57112344A
Authority
JP
Japan
Prior art keywords
intermediates
pharmacological
naphthalene
hydroxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56147723A
Other languages
English (en)
Other versions
JPS6158456B2 (ja
Inventor
Rosu Jiyonson Maikeru
Shieaman Merubin Jiyu Roorensu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS57112344A publication Critical patent/JPS57112344A/ja
Publication of JPS6158456B2 publication Critical patent/JPS6158456B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/42—Halogenated derivatives containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
JP56147723A 1980-09-19 1981-09-18 Pharmacological 4-(2-hydroxy-4-(substituted)phenyl)- naphthalene-2(1h)-one and 2-ol, their derivatives and their intermediates Granted JPS57112344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,402 US4285867A (en) 1980-09-19 1980-09-19 Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor

Publications (2)

Publication Number Publication Date
JPS57112344A true JPS57112344A (en) 1982-07-13
JPS6158456B2 JPS6158456B2 (ja) 1986-12-11

Family

ID=22697189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56147723A Granted JPS57112344A (en) 1980-09-19 1981-09-18 Pharmacological 4-(2-hydroxy-4-(substituted)phenyl)- naphthalene-2(1h)-one and 2-ol, their derivatives and their intermediates

Country Status (27)

Country Link
US (1) US4285867A (ja)
EP (1) EP0049953B1 (ja)
JP (1) JPS57112344A (ja)
KR (1) KR850001337B1 (ja)
AR (1) AR228617A1 (ja)
AT (1) ATE7487T1 (ja)
AU (1) AU526673B2 (ja)
CA (2) CA1166639A (ja)
CS (4) CS221989B2 (ja)
DD (2) DD206986A5 (ja)
DE (1) DE3163651D1 (ja)
DK (1) DK415281A (ja)
ES (2) ES505625A0 (ja)
FI (1) FI75143C (ja)
GR (1) GR75346B (ja)
HU (1) HU191337B (ja)
IE (1) IE51630B1 (ja)
IL (1) IL63869A (ja)
IN (1) IN157167B (ja)
NO (2) NO813186L (ja)
NZ (2) NZ206872A (ja)
PH (1) PH17616A (ja)
PL (5) PL133727B1 (ja)
PT (1) PT73700B (ja)
SU (2) SU1217248A3 (ja)
YU (2) YU225981A (ja)
ZA (1) ZA816489B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000239214A (ja) * 1998-12-25 2000-09-05 Dainippon Ink & Chem Inc デカヒドロナフタレン誘導体及びその製造方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593131A (en) * 1980-09-19 1986-06-03 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4360700A (en) * 1981-11-02 1982-11-23 Pfizer Inc. Intermediates for making 1-(3-benzyloxyphenyl)-1,1-dimethylheptane
CN107915633A (zh) * 2017-12-06 2018-04-17 安徽绩溪县徽煌化工有限公司 一种间苄氧基苯甲酸甲酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB464328A (en) * 1935-10-09 1937-04-09 Henkel & Cie Gmbh Improvements in or relating to the manufacture of hydroarylated aromatic hydroxy compounds and derivatives thereof
US2993056A (en) * 1956-08-31 1961-07-18 Istituto Sieroterapico Italian Production of the 1-6-lactone of 6-hydroxy-8-acetoxy-octanoic acid
US2886589A (en) * 1957-08-05 1959-05-12 Merck & Co Inc 8-methyl-5-oxyphenyl hexahydroindan compounds
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
US3378589A (en) * 1967-05-01 1968-04-16 American Cyanamid Co Process of preparing the ring b carbon analog of griseofulvin
US3576887A (en) * 1967-05-01 1971-04-27 American Home Prod Process for the preparation of oxaphenanthrenes and intermediates therefor
US3974157A (en) * 1974-03-04 1976-08-10 Pennwalt Corporation 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
US4283569A (en) * 1977-09-13 1981-08-11 Pfizer Inc. Hydroxyalkyl and oxoalkyl substituted phenols as analgesics and sedatives
PT68543A (en) 1977-09-13 1978-10-01 Pfizer Process for the preparation of 3-2-hydroxi-4-substituted -phenyl cycloalkanone and cycloalkanol analgesic agents andintermediates therefor
SE431085B (sv) * 1977-09-13 1984-01-16 Pfizer 3-(2-hydroxi-4-(substituerade)fenyl)cykloalkanoner och -cykloalkanoder och vissa derivat derav till anvendning for farmakologiska och medicinska endamal
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000239214A (ja) * 1998-12-25 2000-09-05 Dainippon Ink & Chem Inc デカヒドロナフタレン誘導体及びその製造方法

Also Published As

Publication number Publication date
PL135169B1 (en) 1985-10-31
AU526673B2 (en) 1983-01-27
ES8301872A1 (es) 1982-12-16
YU149283A (en) 1983-12-31
KR830007592A (ko) 1983-11-04
DK415281A (da) 1982-03-20
GR75346B (ja) 1984-07-13
PL237443A1 (en) 1983-02-14
HU191337B (en) 1987-02-27
AU7547481A (en) 1982-06-10
NZ206872A (en) 1984-12-14
SU1217249A3 (ru) 1986-03-07
PT73700B (en) 1983-10-19
CA1166639A (en) 1984-05-01
DD209434A5 (de) 1984-05-09
CA1171416A (en) 1984-07-24
ES505625A0 (es) 1982-12-16
IL63869A (en) 1985-03-31
PH17616A (en) 1984-10-05
PL233104A1 (ja) 1982-11-08
CS221991B2 (en) 1983-04-29
DD206986A5 (de) 1984-02-15
CS221989B2 (en) 1983-04-29
YU225981A (en) 1984-02-29
JPS6158456B2 (ja) 1986-12-11
EP0049953A2 (en) 1982-04-21
KR850001337B1 (ko) 1985-09-19
IN157167B (ja) 1986-02-01
ES514376A0 (es) 1983-05-01
FI75143C (fi) 1988-05-09
CS221988B2 (en) 1983-04-29
IE51630B1 (en) 1987-01-21
SU1217248A3 (ru) 1986-03-07
EP0049953A3 (en) 1982-12-08
ZA816489B (en) 1982-09-29
ATE7487T1 (de) 1984-06-15
FI812927L (fi) 1982-03-20
US4285867A (en) 1981-08-25
PL237442A1 (en) 1983-02-14
CS221990B2 (en) 1983-04-29
IE812185L (en) 1982-03-19
NZ198390A (en) 1984-12-14
PL133727B1 (en) 1985-06-29
NO823160L (no) 1982-03-22
PL134880B1 (en) 1985-09-30
ES8306087A1 (es) 1983-05-01
PL138052B1 (en) 1986-08-30
PL237441A1 (en) 1983-02-14
AR228617A1 (es) 1983-03-30
EP0049953B1 (en) 1984-05-16
DE3163651D1 (en) 1984-06-20
IL63869A0 (en) 1981-12-31
PL131787B1 (en) 1985-01-31
FI75143B (fi) 1988-01-29
NO813186L (no) 1982-03-22
PT73700A (en) 1981-10-01

Similar Documents

Publication Publication Date Title
NZ200586A (en) 1,2-diaminocyclobutene-3,4-dione derivatives and intermediates
IL64761A (en) D-phenylalanyl-l-prolyl-l-arginine aldehyde sulfate,its preparation and intermediates therefor
AU556515B2 (en) 1-hydroxyethyl-azole derivatives and intermediates
ZA872999B (en) Thienopyrimidine-2,4-dione derivatives and intermediates thereof
NZ217511A (en) Aryl-pyridone (and thione) derivatives, intermediates and insecticidal compositions
DE3577089D1 (de) Antibakterielle chinolinderivate.
NO167293C (no) Mellomprodukter.
DK318985A (da) Fremgangsmaade til fremstilling af 5-aryl-1,6-naphthyridin-2(1h)-on-derivater samt mellemprodukter til brug ved fremgangsmaaden
ZA814563B (en) Isoxazolylimidazolidione derivatives intermediates, formulations and herbicidal method
PH17499A (en) Herbicidally active novel substituted phenylsulfonylurea derivatives and new intermediates therefor
GB2000761B (en) 9-hydrohexa-hydroibenzo b, d pyrans, 1-substituted 9-hydrohexahydroibenzo b, d pyrans and intermediates therefor
EP0043054A3 (en) Pyrimidine derivatives, their preparation and use, medicaments containing them and intermediates for their preparation
GB2191191B (en) Herbicidal 5-amino-3-oxo-4-(substituted--phenyl)-2,3-dihydrothiophene and derivatives thereof
IL63869A0 (en) Pharmacologically active 4-(2-hydroxy-4-(substituted)phenyl)naphthalen-2(1h)-ones and 2-ols,derivatives thereof and intermediates therefor
AU5861890A (en) Intermediates of 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivatives
FI861204A0 (fi) Foerfarande och anordning foer reglering av klimatfoerhaollandena i samband med pollination av vaexthusvaexter.
BE890853A (fr) Nouveaux derives de l'apramycine
ZA816492B (en) Pharmacologically active 2-hydroxy-4-(substituted)phenyl cycloalkanes,derivatives thereof and intermediates therefor
SE8101204L (sv) Forfarande for framstellning av 5-cyano-(3,4'-bipyridin)-6(1h)-on
FI824370L (fi) Foerfarande foer framstaellning av 1-alkyl-6,7-metylendioxy-4(1h)-oxo-cinnolin-3-karboxylsyra
EP0076017A3 (en) Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor
JPS57156431A (en) Novel drugs and novel compounds comprising 6-position bisubstituted 3-hydroxydodeca hydrobenzo(e)indene-7-one, manufacture and obtained novel intermediates
GB2229720B (en) Heterocyclic intermediates
ZA817866B (en) Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor
AU547554B2 (en) 2,4(1h,3h)-quinazoline diones